Gregory D. Russell, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 49 State Rd, North Dartmouth, MA 02747 Phone: 508-973-6650 Fax: 508-973-0345 |
David Stebbins, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 49 State Road, Pequot Bldg, Ste 104, North Dartmouth, MA 02747 Phone: 508-973-6650 Fax: 508-973-0345 |
Mr. Michael J Rocha, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 535 Faunce Corner Rd, Hawthorn Medical Assoicates, North Dartmouth, MA 02747 Phone: 508-996-3991 |
Mark R. Desnoyers, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 49 State Road, Pequot Bldg, Ste 104, North Dartmouth, MA 02740 Phone: 508-973-6650 Fax: 508-973-0345 |
News Archive
A new study has shown that glial cells of the gut (part of the enteric nervous system) when exposed to secretions from colon cancer cells are convert into tumours themselves. These altered glial cells then convert into promoters of tumours said the study researchers.
"The prescription drug industry's lobbying arm is defending its deal with President Barack Obama in the wake of criticism from House Minority Leader John Boehner, who charged it with 'appeasing' the Obama administration," The Hill reports.
The current assumed pedestrian walking speed of 1.2 m per second should be revised, say researchers whose findings show that the average UK resident over the age of 65 years does not walk at this pace.
Researchers have discovered a novel and druggable insulin inhibitory receptor, named inceptor. The latest study from Helmholtz Zentrum Muenchen, the Technical University of Munich and the German Center for Diabetes Research is a significant milestone for diabetes research as the scientific community celebrates 100 years of insulin and 50 years of insulin receptor discovery.
Breast cancer patients treated with anthracycline-based chemotherapy regimens may be at greater risk of neurocognitive problems than those given nonanthracycline regimens, indicate findings.
› Verified 8 days ago